Recruiting

Phenylephrine vs. Norepinephrine

Sponsor:

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Code:

NCT00294606

Conditions

Vasopressor Agents

Endarterectomy, Carotid

Echocardiography, Transesophageal

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Comparison of Effects of Phenylephrine and Norepinephrine

Study Details

Brief summary:

This will be a prospective, randomized, double-blinded, cross-over clinical trial to compare the effects of phenylephrine or norepinephrine on cardiac function during carotid artery surgery in patients under general anesthesia. The effect of the vasopressor on cardiac function will be measured using electrocardiography, transesophageal echocardiography and cardiac troponin I intraoperatively and postoperatively. We will use a cross-over pattern since both drugs exhibit rapid onset and short duration of action. We hypothesize that there will be less myocardial ischemia associated with the use of norepinephrine when compared with phenylephrine during carotid artery surgery.

Conditions

Vasopressor Agents

Endarterectomy, Carotid

Echocardiography, Transesophageal

Study ID

NCT00294606

Start date

Feb, 2006

Status verified date

Feb, 2006

Completion date

Feb, 2006

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Elective carotid endarterectomy under general anesthesia
  • > 18 years old
  • Written informed consent

Exclusion Criteria:

  • Contraindication to general anesthesia
  • Contraindication to transesophageal anesthesia
  • esophageal disease
  • esophageal stricture
  • history of esophageal or gastric bleeding
  • esophageal anatomic abnormality
  • past esophageal or gastric surgery
  • severe dysphagia

Study Design

Enrollment

86 participants

Allocation

Randomized

Intervention Model

Crossover

Interventions and Outcome Measures

Interventions

Comparison of Effects of Phenylephrine and Norepinephrine

Primary outcome measure

  • Myocardial ischemia measures by transesophageal echocardiography and ST segment analyses [ Time Frame: undefined ]

Central Contacts and Locations

Central contacts

Rosemary A Craen, MD, FRCPC

(519) 663-3022rosemary.craen@lhsc.on.ca

Hélène G Pellerin, MD, FRCPC

(519) 663-3022hpelleri@uwo.ca

Locations

University Hospital, LHSC

Recruiting

London, Ontario, Canada, N6A 5A5

Contacts

Rosemary A Craen, MD, FRCPC

(519) 663-3022Rosemary.Craen@lhsc.on.ca

Principal Investigator:

Rosemary A Craen, MD, FRCPC

More Information

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Last update posted

Feb 22, 2006

Last verified

Feb, 2006

Keywords

  • vasopressor agents
  • carotid endarterectomy
  • cardiac function
  • transesophageal echocardiography
  • wall motion abnormalities

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's on 2006-02-22.